文献速递精神分裂症与精神病性障碍

精神分裂症患者诱导多能干细胞来源脑类器官的转录组特征与功能研究

Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell-Derived Cerebral Organoids in Schizophrenia.
PubMed 文献 · JAMA Psychiatry · 2020-01-01

该病例对照研究在麻省总医院开展,对8例精神分裂症患者和8名健康对照的iPSC来源脑类器官进行转录组分析,发现突触、神经发育和抗原加工相关基因差异表达,且差异基因富集于GWAS基因;线粒体呼吸功能降低,微电极阵列显示对刺激和去极化的反应减弱。

要点

  • 精神分裂症患者脑类器官中突触生物学和神经发育相关基因表达异常。
  • 差异表达基因富集于精神分裂症GWAS位点,23%的GWAS基因有差异表达。
  • 患者脑类器官线粒体呼吸功能降低,对刺激和去极化的电生理反应减弱。

核心结论

  • 精神分裂症患者来源脑类器官存在多条通路失调,线粒体功能降低,且对刺激和去极化的反应减弱。

研究设计与样本

  • 病例对照研究,纳入8例精神分裂症患者和8名健康对照,在麻省总医院于2017至2019年开展。
  • 研究对象为11名男性和5名女性白人,平均年龄38.8岁。

主要发现

  • RNA测序显示突触、神经系统发育和抗原加工相关基因差异表达。
  • 23%的精神分裂症GWAS基因在患者与对照类器官中差异表达,其中10个上调、15个下调。
  • 基因表达谱提示线粒体功能及兴奋/抑制通路调节相关基因失调。
  • 患者脑类器官基础耗氧率、ATP产量、质子漏和非线粒体耗氧量均降低,细胞外酸化率无差异。
  • 微电极阵列显示患者脑类器官基线电活动无差异,但对刺激和去极化的反应减弱。

临床怎么用

  • 患者来源脑类器官可作为一种模型,用于研究精神分裂症的细胞分子机制。
  • 转录组和线粒体功能指标可能为理解精神分裂症病理生理提供线索。

局限性

  • 样本量较小,仅纳入白人参与者,结果推广需谨慎。
  • 研究为体外模型,不能完全反映体内复杂环境。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Three-dimensional cerebral organoids generated from patient-derived induced pluripotent stem cells (iPSCs) may be used to interrogate cellular-molecular underpinnings of schizophrenia. OBJECTIVE: To determine transcriptomic profiles and functional characteristics of cerebral organoids from patients with schizophrenia using gene expression studies, complemented with investigations of mitochondrial function through measurement of real-time oxygen consumption rate, and functional studies of neuronal firing with microelectrode arrays. DESIGN, SETTING, AND PARTICIPANTS: This case-control study was conducted at Massachusetts General Hospital between 2017 and 2019. Transcriptomic profiling of iPSC-derived cerebral organoids from 8 patients with schizophrenia and 8 healthy control individuals was undertaken to identify cellular pathways that are aberrant in schizophrenia. Induced pluripotent stem cells and cerebral organoids were generated from patients who had been diagnosed as having schizophrenia and from heathy control individuals. MAIN OUTCOMES AND MEASURES: Transcriptomic analysis of iPSC-derived cerebral organoids from patients with schizophrenia show differences in expression of genes involved in synaptic biology and neurodevelopment and are enriched for genes implicated in schizophrenia genome-wide association studies (GWAS). RESULTS: The study included iPSC lines generated from 11 male and 5 female white participants, with a mean age of 38.8 years. RNA sequencing data from iPSC-derived cerebral organoids in schizophrenia showed differential expression of genes involved in synapses, in nervous system development, and in antigen processing. The differentially expressed genes were enriched for genes implicated in schizophrenia, with 23% of GWAS genes showing differential expression in schizophrenia and control organoids: 10 GWAS genes were upregulated in schizophrenia organoids while 15 GWAS genes were downregulated. Analysis of the gene expression profiles suggested dysregulation of genes involved in mitochondrial function and those involved in modulation of excitatory and inhibitory pathways. Studies of mitochondrial respiration showed lower basal consumption rate, adenosine triphosphate production, proton leak, and nonmitochondrial oxygen consumption in schizophrenia cerebral organoids, without any differences in the extracellular acidification rate. Microelectrode array studies of cerebral organoids showed no differences in baseline electrical activity in schizophrenia but revealed a diminished response to stimulation and depolarization. CONCLUSIONS AND RELEVANCE: Investigations of patient-derived cerebral organoids in schizophrenia revealed gene expression patterns suggesting dysregulation of a number of pathways in schizophrenia, delineated differences in mitochondrial function, and showed deficits in response to stimulation and depolarization in schizophrenia.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kathuria A, Lopez-Lengowski K, Jagtap SS, et al. Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell-Derived Cerebral Organoids in Schizophrenia. JAMA Psychiatry. 2020. PMID: 32186681. doi:10.1001/jamapsychiatry.2020.0196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。